Zobrazeno 1 - 10
of 331
pro vyhledávání: '"Andrea, Decensi"'
Autor:
Harriet Johansson, Aliana Guerrieri-Gonzaga, Sara Gandini, Bjørn-Erik Bertelsen, Debora Macis, Davide Serrano, Gunnar Mellgren, Matteo Lazzeroni, Parijatham S. Thomas, Katherine D. Crew, Nagi B. Kumar, Irene Maria Briata, Viviana Galimberti, Giuseppe Viale, Lana A. Vornik, Valentina Aristarco, Tania Buttiron Webber, Stefano Spinaci, Powel H. Brown, Brandy M. Heckman-Stoddard, Eva Szabo, Bernardo Bonanni, Andrea DeCensi
Publikováno v:
npj Breast Cancer, Vol 10, Iss 1, Pp 1-8 (2024)
Abstract In a 3-arm presurgical trial, four-six weeks exemestane 25 mg three times/week (TIW) was non-inferior to 25 mg/day (QD) in suppressing circulating estradiol in postmenopausal women with ER-positive breast cancer. Since obesity may decrease e
Externí odkaz:
https://doaj.org/article/d80f769e4684451285f4994baf3c0f8c
Autor:
Laura Paleari, Mariangela Rutigliani, Oriana D’Ecclesiis, Sara Gandini, Irene Maria Briata, Tania Buttiron Webber, Nicoletta Provinciali, Andrea DeCensi
Publikováno v:
International Journal of Translational Medicine, Vol 3, Iss 4, Pp 479-486 (2023)
Background: Up to now, endometrial cancer (EC) treatments are mainly represented by surgery followed by adjuvant chemotherapy or radiotherapy. The updated guidelines give a 2A recommendation for the use of hormone therapy only in advanced low-grade E
Externí odkaz:
https://doaj.org/article/7d2d3821a61f4feaafa7f921b4c32ca7
Autor:
Nicoletta Provinciali, Marco Piccininno, Giacomo Siri, Alessandra Gennari, Giancarlo Antonucci, Damiano Ricci, Emmanuela Devoto, Roberta Miceli, Pietro Cortesi, Chiara Pazzi, Oriana Nanni, Francesca Mannozzi, Ilaria Pastina, Luciana Messuti, Carmelo Bengala, Giovanni Luca Frassineti, Carlo Cattrini, Marianna Fava, Tania Buttiron Webber, Irene Maria Briata, Davide Corradengo, Andrea DeCensi, Matteo Puntoni
Publikováno v:
Reviews in Cardiovascular Medicine, Vol 25, Iss 7, p 256 (2024)
Background: Serum biomarkers have been investigated as predictive risk factors for cancer-related cardiovascular (CV) risk, but their analysis is limited to their baseline level rather than their overtime change. Besides historically validated causal
Externí odkaz:
https://doaj.org/article/91d1f5ff789a46eebfeceec88c5656dd
Autor:
Aliana Guerrieri-Gonzaga, Davide Serrano, Patrizia Gnagnarella, Harriet Johansson, Stefania Zovato, Mariateresa Nardi, Matilde Pensabene, Simona Buccolo, Andrea DeCensi, Irene Maria Briata, Luigi Pistelli, Clementina Sansone, Sara Mannucci, Valentina Aristarco, Debora Macis, Matteo Lazzeroni, Gaetano Aurilio, Chiara Arianna Accornero, Sara Gandini, Bernardo Bonanni
Publikováno v:
PLoS ONE, Vol 19, Iss 9, p e0309511 (2024)
BackgroundBreast Cancer (BC) prevention strategies range from lifestyle changes such as increasing physical activity and reducing body weight to preventive drugs like tamoxifen, known to reduce BC incidence in high-risk women. Sex Hormone Binding Glo
Externí odkaz:
https://doaj.org/article/3b6439e091ed4e8d803f9e8de86b05a6
Autor:
Nicoletta Provinciali, Marco Greppi, Silvia Pesce, Mariangela Rutigliani, Irene Maria Briata, Tania Buttiron Webber, Marianna Fava, Andrea DeCensi, Emanuela Marcenaro
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Despite recent advances in ovarian cancer (OC) treatment, including the introduction of bevacizumab and PARP-inhibitors, OC remains a lethal disease. Other therapeutic options are being explored, such as immunotherapy (IT), which has been proved effe
Externí odkaz:
https://doaj.org/article/f05da879a9e94a93962d686d0e4e541a
Autor:
Nicoletta Provinciali, Laura Paleari, Irene Maria Briata, Arnoldo Piccardo, Lorenzo Bacigalupo, Mariangela Rutigliani, Andrea DeCensi
Publikováno v:
Current Problems in Cancer: Case Reports, Vol 7, Iss , Pp 100172- (2022)
Until recently endometrial cancer has classically been divided into two categories, type 1 estrogen-dependent and predominantly endometrioid and type 2 estrogen-independent and predominantly serous, according to etiological and morphological factors.
Externí odkaz:
https://doaj.org/article/6e184c8f8ad34750abd08537edec405d
Autor:
Andrea DeCensi, Harriet Johansson, Thomas Helland, Matteo Puntoni, Debora Macis, Valentina Aristarco, Silvia Caviglia, Tania Buttiron Webber, Irene Maria Briata, Mauro D’Amico, Davide Serrano, Aliana Guerrieri-Gonzaga, Ersilia Bifulco, Steinar Hustad, Håvard Søiland, Luca Boni, Bernardo Bonanni, Gunnar Mellgren
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-5 (2021)
Abstract Low-dose tamoxifen halves recurrence in non-invasive breast cancer without significant adverse events. Some adjuvant trials with tamoxifen 20 mg/day had shown an association between low endoxifen levels (9–16 nM) and recurrence, but no ass
Externí odkaz:
https://doaj.org/article/970405befd6e48368a4c4d7033f964aa
Autor:
Mariella Della Chiesa, Chiara Setti, Chiara Giordano, Valentina Obino, Marco Greppi, Silvia Pesce, Emanuela Marcenaro, Mariangela Rutigliani, Nicoletta Provinciali, Laura Paleari, Andrea DeCensi, Simona Sivori, Simona Carlomagno
Publikováno v:
Vaccines, Vol 10, Iss 7, p 1033 (2022)
Human Natural Killer (NK) cells are all round players in immunity thanks to their powerful and immediate response against transformed cells and the ability to modulate the subsequent adaptive immune response. The potential of immunotherapies based on
Externí odkaz:
https://doaj.org/article/3b8165208dec4d8e81527873a4f75925
Autor:
Gemma Palazzolo, Hilaria Mollica, Valeria Lusi, Mariangela Rutigliani, Martina Di Francesco, Rui Cruz Pereira, Marco Filauro, Laura Paleari, Andrea DeCensi, Paolo Decuzzi
Publikováno v:
Translational Oncology, Vol 13, Iss 4, Pp - (2020)
Although screening has reduced mortality rates for colorectal cancer (CRC), about 20% of patients still carry metastases at diagnosis. Postsurgery chemotherapy is toxic and induces drug resistance. Promising alternative strategies rely on repurposing
Externí odkaz:
https://doaj.org/article/3db5ffe3802d4874ae36b211c0daf6fd
Autor:
Marilena Petrera, Laura Paleari, Matteo Clavarezza, Matteo Puntoni, Silvia Caviglia, Irene Maria Briata, Massimo Oppezzi, Eva Mihajlovic Mislej, Borut Stabuc, Michael Gnant, Thomas Bachleitner-Hofmann, Wilfried Roth, Dominique Scherer, Walter-E. Haefeli, Cornelia M. Ulrich, Andrea DeCensi
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-9 (2018)
Abstract Background Epidemiological studies and cardiovascular prevention trials have shown that low-dose aspirin can reduce colorectal cancer (CRC) incidence and mortality, including inhibition of distant metastases. Metformin has also been associat
Externí odkaz:
https://doaj.org/article/071bd15d14c14ce58107037b607afc2f